InvestSMART

Suda Pharmaceuticals Ltd (ASX: SUD) - Announcements

- Current share price for SUD : $0.048

ASX company news and announcements for Suda Pharmaceuticals Ltd (SUD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Suda Pharmaceuticals Ltd (SUD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Suda Pharmaceuticals Ltd (SUD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Suda Pharmaceuticals Ltd (SUD)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
- Investor Presentation 28 Aug 2018 11:16AM $0.005 $0.048 risen by 860%
- SUDA Expands Patent Coverage For Sildenafil Sprays 22 Aug 2018 8:20AM $0.006 $0.048 risen by 700%
- SUDA Achieves TGA GMP Licence 21 Aug 2018 8:24AM $0.005 $0.048 risen by 860%
- Top 20 securityholders 14 Aug 2018 1:12PM $0.005 $0.048 risen by 860%
- Change of Directors' Interest Notice 3 Aug 2018 11:16AM $0.005 $0.048 risen by 860%
- Rights Issue and Placement Completed and Appendix 3B 2 Aug 2018 12:00PM $0.005 $0.048 risen by 860%
- Rights Issue Closes Significantly Oversubscribed 31 Jul 2018 6:27PM $0.006 $0.048 risen by 772.73%
- Supplementary Prospectus 31 Jul 2018 6:25PM $0.006 $0.048 risen by 772.73%
- Appendix 4C - quarterly 31 Jul 2018 6:20PM $0.006 $0.048 risen by 772.73%
- Change of Director's Interest Notice 31 Jul 2018 6:18PM $0.006 $0.048 risen by 772.73%
- David Phillips To Lead Business Development 25 Jul 2018 8:18AM $0.005 $0.048 risen by 860%
- Corporate Presentation 17 Jul 2018 8:23AM $0.005 $0.048 risen by 860%
- ASX Waiver To Grant Secured Convertible Notes 16 Jul 2018 12:51PM $0.005 $0.048 risen by 860%
- Business Development Update 16 Jul 2018 8:23AM $0.005 $0.048 risen by 860%
- Anagrelide Update 12 Jul 2018 9:28AM $0.005 $0.048 risen by 860%
- Letter to Ineligible Shareholders 2 Jul 2018 9:37AM n/a $0.048 n/a
- Letter to Eligible Shareholders 2 Jul 2018 9:37AM n/a $0.048 n/a
- Prospectus for a Renounceable Pro Rata Offer 2 Jul 2018 9:37AM n/a $0.048 n/a
- Appendix 3B 2 Jul 2018 9:37AM n/a $0.048 n/a
- Settlement with HC Berlin Pharma and Rights Issue 2 Jul 2018 9:37AM n/a $0.048 n/a
- Trading Halt 28 Jun 2018 9:14AM $0.008 $0.048 risen by 500%
- Shareholder Update 21 Jun 2018 8:26AM $0.009 $0.048 risen by 433.33%
- SUDA Expands Patent Coverage For Sildenafil 18 Jun 2018 9:03AM $0.009 $0.048 risen by 433.33%
- SUDA announces update on ZolpiMist in USA and Canada 15 Jun 2018 11:18AM $0.009 $0.048 risen by 433.33%
- SUDA Establishes Scientific Advisory Board 15 May 2018 9:06AM $0.012 $0.048 risen by 300%

226 - 250 of 445 results

Page 10 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.